Skip to content

Pharminent

cropped-ChatGPT-Image-May-26-2026-09_44_59-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Other
  • New NIHR-funded TRC for Parkinson’s disease
  • Other

New NIHR-funded TRC for Parkinson’s disease

Pharmaphorum

The launch of a new national research collaboration focused on Parkinson's disease has been announced.

Neuroscience

Read full story

pharminent April 27, 2026 (Last updated: April 27, 2026)

Pharmaphorum

The launch of a new national research collaboration focused on Parkinson’s disease has been announced.

Neuroscience

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Lilly falls on slower start for Foundayo versus Wegovy
Next: Novartis secures pair of regulatory wins for skin disease and malaria treatments

Related Stories

  • Other

All eyes on Revolution, bispecific antibodies and more at ASCO26

pharminent May 26, 2026
  • Other

225: An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator

pharminent May 18, 2026
  • Other

Cellbxhealth partners with AdventHealth on CTCbased monitoring in two major cancer studies

pharminent May 18, 2026

You May Have Missed

wp_feature_2026-05-27
  • News

pharminent May 27, 2026
  • M&A / Deals

Apogee investors riled by $1.3B royalty deal, as eczema drug matches Lilly’s Ebglyss

pharminent May 27, 2026
  • Commercial

Kardigan targets IPO to support cardiology pipeline progression

pharminent May 27, 2026
  • Regulatory

FDA delays verdict on AZ breast cancer drug

pharminent May 27, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.